Northern Trust Corp Corbus Pharmaceuticals Holdings, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.11 - $5.46 $605 - $30,057	-5,505 Reduced 2.59%	207,329 $22,000
Q2 2022 Aug 12, 2022	SELL	$0.21 - $0.53 $81 - $205	-388 Reduced 0.18%	212,834 $53,000
Q1 2022 May 13, 2022	SELL	$0.32 - $0.67 $120 - $251	-375 Reduced 0.18%	213,222 $113,000
Q4 2021 Feb 08, 2022	SELL	$0.6 - $1.11 $2,440 - $4,515	-4,068 Reduced 1.87%	213,597 $132,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $4,381 - $7,895	4,338 Added 2.03%	217,665 $222,000
Q2 2021 Aug 13, 2021	SELL	$1.39 - $2.21 $811,929 - $1.29 Million	-584,122 Reduced 73.25%	213,327 $390,000
Q1 2021 May 12, 2021	SELL	$1.27 - $3.42 $38,602 - $103,954	-30,396 Reduced 3.67%	797,449 $1.57 Million
Q4 2020 Feb 11, 2021	SELL	$0.94 - $1.89 $6,909 - $13,893	-7,351 Reduced 0.88%	827,845 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $82,495 - $515,871	54,997 Added 7.05%	835,196 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $57,393 - $100,528	-11,982 Reduced 1.51%	780,199 $6.55 Million
Q1 2020 May 14, 2020	BUY	$3.44 - $7.21 $331,719 - $695,260	96,430 Added 13.86%	792,181 $4.15 Million
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $19,292 - $25,363	4,497 Added 0.65%	695,751 $3.8 Million
Q3 2019 Nov 13, 2019	BUY	$4.87 - $7.08 $395,278 - $574,655	81,166 Added 13.3%	691,254 $3.37 Million
Q2 2019 Aug 13, 2019	SELL	$6.6 - $7.8 $132,006 - $156,007	-20,001 Reduced 3.17%	610,088 $4.23 Million
Q1 2019 May 13, 2019	BUY	$5.76 - $8.95 $248,256 - $385,744	43,100 Added 7.34%	630,089 $4.38 Million
Q4 2018 Feb 12, 2019	SELL	$5.26 - $7.97 $44,731 - $67,776	-8,504 Reduced 1.43%	586,989 $3.43 Million
Q3 2018 Nov 14, 2018	BUY	$4.65 - $7.95 $107,731 - $184,185	23,168 Added 4.05%	595,493 $4.5 Million
Q2 2018 Sep 18, 2018	SELL	$5.05 - $6.8 $18,876 - $25,418	-3,738 Reduced 0.65%	572,325 $2.89 Million
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $222,674 - $299,839	44,094 Added 8.29%	576,063 $2.91 Million
Q1 2018 May 09, 2018	BUY	$5.6 - $9.25 $43,764 - $72,288	7,815 Added 1.49%	531,969 $3.25 Million
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $147,701 - $174,108	22,379 Added 4.46%	524,154 $3.72 Million
Q3 2017 Nov 13, 2017	BUY	$5.75 - $7.75 $2.89 Million - $3.89 Million	501,775	501,775 $3.59 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account